Lastimado, Generose M.

HRN: 11-89-97  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/06/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
12/06/2022
12/12/2022
IVT
4.5g IVT Now ANST Then 2.25g IVT Q8
4.5g IVT Now ANST Then 2.25g IVT Q8
Cystic Fibrosis; CAP MR
Waiting Final Action 

Indication:  Empirical Escalation    Type of Infection:  Pneumonia    Compliance to guidelines: Guideline Not Available

Initial appropriateness: Yes   

Final appropriateness: No  Wrong Dose  Wrong Dose

Overall appropriateness: No  Wrong Dose

Intervention



Type of Intervention done:

                    

           


Acceptance: